(Q45057748)

9 December 2017

title

Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy (English)

1 reference

9 December 2017

Astrid Zobel

1

1 reference

9 December 2017

Jörg Wellmer

2

1 reference

9 December 2017

Svenja Schulze-Rauschenbach

3

1 reference

9 December 2017

Ute Pfeiffer

4

1 reference

9 December 2017

Susanne Schnell

5

1 reference

9 December 2017

Christian Elger

6

1 reference

9 December 2017

Wolfgang Maier

7

1 reference

9 December 2017

publication date

1 October 2004

1 reference

European Archives of Psychiatry and Clinical Neuroscience

9 December 2017

published in

1 reference

9 December 2017

volume

254

1 reference

9 December 2017

issue

5

1 reference

9 December 2017

page(s)

303-311

1 reference

Depression and Anxiety in Patients with Epilepsy

9 December 2017

cites work

1 reference

12 December 2020

Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial

1 reference

12 December 2020

Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease.

1 reference

12 December 2020

Antiepileptic drug interactions.

1 reference

12 December 2020

Effects of adverse experiences for brain structure and function

1 reference

12 December 2020

GABAergic mechanisms in epilepsy

1 reference

12 December 2020

Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion

1 reference

12 December 2020

Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis

1 reference

12 December 2020

Psychiatric Manifestations in Temporal Lobe Epilepsy: A Controlled Study

1 reference

12 December 2020

Vagus nerve stimulation therapy: a research update

1 reference

12 December 2020

The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.

1 reference

12 December 2020

Changes at multiple levels of the hypothalamo-pituitary adrenal axis following repeated electrically induced seizures

1 reference

12 December 2020

Hippocampal atrophy in recurrent major depression

1 reference

12 December 2020

Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I

1 reference

12 December 2020

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders

1 reference

12 December 2020

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

1 reference

12 December 2020

Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders

1 reference

12 December 2020

Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis

1 reference

12 December 2020

Vagus nerve stimulation. A potential therapy for resistant depression?

1 reference

12 December 2020

The plasma dexamethasone variable in depression: test-retest studies and early biophase kinetics.

1 reference

12 December 2020

Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management

1 reference

12 December 2020

1 reference

12 December 2020

Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression

1 reference

12 December 2020

Endocrine abnormalities in human temporal lobe epilepsy

1 reference

12 December 2020

Plasticity of the hippocampus: adaptation to chronic stress and allostatic load.

1 reference

12 December 2020

Cellular pathology of amygdala neurons in human temporal lobe epilepsy

1 reference

12 December 2020

The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis

1 reference

12 December 2020

Localization and characterization of cytochrome P450 in the brain. In vivo and in vitro investigations on phenytoin- and phenobarbital-inducible isoforms

1 reference

12 December 2020

Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II

1 reference

12 December 2020

Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study

1 reference

12 December 2020

Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects

1 reference

12 December 2020

Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation

1 reference

12 December 2020

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

1 reference

12 December 2020

Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation

1 reference

12 December 2020

Enlargement of the amygdala in patients with a first episode of major depression

1 reference

12 December 2020

The neuroendocrinology of depression and chronic stress

1 reference

12 December 2020

Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression

1 reference

12 December 2020

Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies

1 reference

12 December 2020

Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment

1 reference

12 December 2020

Mechanisms of action of antiepileptic drugs

1 reference

12 December 2020

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness

1 reference

12 December 2020

Neuroimaging Abnormalities in the Amygdala in Mood Disorders

1 reference

12 December 2020

Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate

1 reference

12 December 2020

A hypothesis to integrate partial seizures of temporal lobe origin and reproductive endocrine disorders

1 reference

12 December 2020

The effects of anti-convulsant drugs on adrenal function

1 reference

12 December 2020

Vagus nerve stimulation: a new form of therapeutic brain stimulation

1 reference

12 December 2020

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

1 reference

12 December 2020

Neuroendocrine aspects of the response to stress

1 reference

12 December 2020

Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression

1 reference

12 December 2020

Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder

1 reference

12 December 2020

The effect of seizures on hormones

1 reference

12 December 2020

Vagus nerve stimulation: a new tool for brain research and therapy.

1 reference

12 December 2020

The dexamethasone suppression test in medicated epileptic patients

1 reference

12 December 2020

Steroids, stability and stress.

1 reference

12 December 2020

Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test

1 reference

12 December 2020

Temporal lobe epilepsy, temporal lobectomy, and major depression

1 reference

12 December 2020

Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis

1 reference

12 December 2020

Psychoneuroendocrine aspects of temporolimbic epilepsy. Part I. Brain, reproductive steroids, and emotions

1 reference

12 December 2020

Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease.

1 reference

12 December 2020

The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal

1 reference

12 December 2020

Autonomic, Neuroendocrine, and Immune Responses to Psychological Stress: The Reactivity Hypothesisa

1 reference

12 December 2020

Therapeutic mechanisms of vagus nerve stimulation

1 reference

12 December 2020

Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis

1 reference

12 December 2020

A New Anatomical Framework for Neuropsychiatric Disorders and Drug Abuse

1 reference

12 December 2020

Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine.

1 reference

12 December 2020

Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders

1 reference

12 December 2020

Vagus nerve stimulation therapy summary: five years after FDA approval

1 reference

12 December 2020

Stress: a risk factor for serious illness

1 reference

12 December 2020

Neuroimaging studies of mood disorders

1 reference

12 December 2020

The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa

1 reference

12 December 2020

Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy

1 reference

12 December 2020

The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment

1 reference

12 December 2020

Chronic electroconvulsive shock treatment elicits up-regulation of CRF and AVP mRNA in select populations of neuroendocrine neurons

1 reference

12 December 2020

10.1007/S00406-004-0499-9

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

1003461944

0 references

1 reference